Please visit the Behavioral Research Grants page or the Division of Cancer Control and Population Sciences (DCCPS) Funding Opportunities page for a complete listing of funding opportunities.
July 13, 2017 (1-2 p.m. EDT) – Webinar on the Family Life, Activity, Sun, Health and Eating (FLASHE) Study: A Resource for Understanding Cancer-Prevention Behaviors Among Parent-Adolescent Dyads
July 13, 2017 (1 - 2 p.m. EDT)
Questions can be posed in advance to firstname.lastname@example.org.
This webinar will discuss aspects of the National Cancer Institute (NCI)-sponsored Family Life, Activity, Sun, Health and Eating (FLASHE) Study, including:
- Publicly available data sets and resources;
- methodology and dyadic features of the study design;
- example findings, such as correlates of health behavior and associations between parents and adolescents on psychosocial and behavioral variables; and
- opportunities for using FLASHE data.
Laura Dwyer, PhD
Cape Fox Facilities Services contractor in support of the NCI Behavioral Research Program (BRP)
Daniel Bornstein, PhD
Department of Health, Exercise, and Sport Science, The Citadel
Immediate Past Chair, Physical Activity Section, American Public Health Association
Intended Audience: Health behavior researchers and students of public health and related fields.
Email your questions in advance to email@example.com.
Dr. Wendy Nelson and Ms. Kathleen Castro provide an overview of these funding opportunities that seek research to assess and describe the current state of oral anticancer medication utilization, delivery, and adherence; identify structural, systemic, and psychosocial barriers to adherence; and develop models and strategies to improve safe and effective delivery of these agents so that clinical outcomes are optimized.
Basic Biobehavioral and Psychological Sciences Branch
Behavioral Research Program
Clinical and Translational Epidemiology Branch
Epidemiology and Genomics Research Program
Office of the Associate Director
Healthcare Delivery Research Program
This funding opportunity announcement (FOA) seeks research that integrates two or more independent data sets to answer novel cancer control and prevention questions. Applicants areeve encouraged to incorporate Integrative Data Analysis (IDA) methods that examine cancer-related behavioral risk factors. Examples of these risk factors include tobacco use, sedentary behavior, poor weight management, lack of medical adherence to screening, and poor vaccine uptake.
Moderator Dr. Jerry Suls provides an overview and background information. Speaker Dr. Richard Moser presents details of the FOA, and technical expert Dr. Michelle Mollica provides information about available data sources.
This webinar provides an overview about the new R01 and R21 funding opportunity announcement, Perception and Cognition Research to Inform Cancer Image Interpretation (PAR-17-125 [R01] and PAR-17-124 [R21]).
This new funding opportunity aims to facilitate research on the perceptual and cognitive processes underlying the performance of cancer image observers in radiology and pathology. The scientific scope of this opportunity will yield insights to improve the accuracy of cancer detection and diagnosis.
This webinar provides key information about the new R01 and R21 funding opportunity announcement, Tobacco Use and HIV in Low and Middle Income Countries (PAR-17-087 [R01] and PAR-17-086 [R21]). Epidemiologist Dr. Mark Parascandola of the National Cancer Institute (NCI) Tobacco Control Research Branch provides an overview of a new funding opportunity that aims to develop and evaluate tobacco cessation interventions tailored to HIV-positive populations - including those with co-morbidities such as tuberculosis (TB) - in low-resource settings in low- and middle-income countries.
This webinar provides information about a new Funding Opportunity Announcement in behavioral research from the National Cancer Institute. Dr. Jerry Suls, Program Director and Senior Scientist, provides an overview of Leveraging Cognitive Neuroscience Research to Improve Assessment of Cancer Treatment Related Cognitive Impairment PAR-16-212 (R01) & PAR-16-213 (R21).
Key time markers for the presentation:
Introduction and logistics: 0.00
General funding information: 6:50
Cognitive Neuroscience: 23:50
Predicting Behavioral Responses: 28:16
Improving Smoking Cessation: 31:56
New Media Environment: 36:33
Integrating Existing Data: 42:11
Behavioral Intervention: 46:45
Associate Director of the NCI Behavioral Research Program, Dr. William Klein, provides an overview of these exciting new funding opportunities:
|Funding Opportunity Announcements||Program Contact|
Predicting Behavioral Responses to Population-Level Cancer Control Strategies
Stimulating Innovations in Behavioral Intervention Research for Cancer Prevention and Control
Niall Bolger, Ph.D., and Jean-Philippe (J-P) Laurenceau, Ph.D., introduce viewers to cross-sectional, dyadic analysis using data from the Family Life, Activity, Sun, Health, and Eating (FLASHE) study. Dyadic data present analytic challenges because they have various sources of interdependence (e.g. non-independence between members of the dyad such as a parent and a child). Flexible analytic tools (e.g. path modeling, multilevel modeling) can accommodate these complexities. Viewers will gain introductory-level understanding of dyadic data analysis. Additional resources, such as sample code for preparing data files and conducting dyadic analyses are available on the FLASHE dyadic resources page.
Niall Bolger, Ph.D.
Professor of Psychology
Jean-Philippe (J-P) Laurenceau, Ph.D.
Professor, Psychological and Brain Sciences
University of Delaware
This funding announcement has expired.
This webinar provides key information about the R01 funding opportunity announcement, Smoking Cessation within the Context of Lung Cancer Screening (RFA-CA- 15-011 [R01]. Program Director and Statistician Stephanie Land of the National Cancer Institute (NCI) Tobacco Control Research Branch provide an overview of this funding opportunity that aims to support the development and test and/or implementation of smoking cessation interventions delivered to current smokers who undergo low-dose computed tomography (LDCT) lung cancer screening.